Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

Bosch, 2000, Complications of cirrhotic. I. Portal hypertension, J Hepatol, 32, 141, 10.1016/S0168-8278(00)80422-5

Ferlitsch, 2012, Von Willebrand factor as new non-invasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhotic, Hepatology, 124, 395

Garcia-Tsao, 1985, Portal pressure, presence of gastroesophageal varices and variceal bleeding, Hepatology, 5, 419, 10.1002/hep.1840050313

Groszmann, 1990, Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage, Gastroenterology, 99, 1401, 10.1016/0016-5085(90)91168-6

Cerqueira, 2012, Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding, Eur J Gastroenterol Hepatol, 24, 551, 10.1097/MEG.0b013e3283510448

Abraldes, 2003, Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhotic, Hepatology, 37, 902, 10.1053/jhep.2003.50133

Merkel, 2000, The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhotic, Hepatology, 32, 930, 10.1053/jhep.2000.19322

D'Amico, 2006, Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhotic: a systematic review, Gastroenterology, 131, 1611, 10.1053/j.gastro.2006.09.013

de Franchis, 2010, Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 53, 762, 10.1016/j.jhep.2010.06.004

Lo, 2002, Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding, Gastroenterology, 123, 728, 10.1053/gast.2002.35351

Garcia-Pagan, 2003, Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT, Hepatology, 37, 1260, 10.1053/jhep.2003.50211

Schepke, 2004, Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic, Hepatology, 40, 65, 10.1002/hep.20284

Sarin, 1999, Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding, N Engl J Med, 340, 988, 10.1056/NEJM199904013401302

Bosch, 2010, Carvedilol for portal hypertension in patients with cirrhotic, Hepatology, 51, 2214, 10.1002/hep.23689

Hemstreet, 2004, Evaluation of carvedilol for the treatment of portal hypertension, Pharmacotherapy, 24, 94, 10.1592/phco.24.1.94.34805

Tsochatzis, 2009, Gastrointestinal bleeding: carvedilol—the best beta-blocker for primary prophylaxis?, Nat Rev Gastroenterol Hepatol, 6, 692, 10.1038/nrgastro.2009.198

Forrest, 1996, Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhotic, J Hepatol, 25, 909, 10.1016/S0168-8278(96)80296-0

Banares, 1999, Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhotic, Hepatology, 30, 79, 10.1002/hep.510300124

Banares, 2002, Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhotic, Hepatology, 36, 1367, 10.1053/jhep.2002.36947

Tripathi, 2009, Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed, Hepatology, 50, 825, 10.1002/hep.23045

Peck-Radosavljevic, 2005, Austrian consensus on the definition and treatment of portal hypertension and its complications, Endoscopy, 37, 667, 10.1055/s-2005-861464

Reiberger, 2011, Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhotic, J Gastroenterol, 47, 561, 10.1007/s00535-011-0517-4

Bosch, 2009, The clinical use of HVPG measurements in chronic liver disease, Nat Rev Gastroenterol Hepatol, 6, 573, 10.1038/nrgastro.2009.149

Reiberger, 2011, Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection, Clin Gastroenterol Hepatol, 9, 602, 10.1016/j.cgh.2011.03.002

Reiberger, 2012, Noninvasive screening for liver fibrosis and portal hypertension by transient elastography-a large single center experience, Wien Klin Wochenschr, 56, 1439

Imperiale, 2001, A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding, Hepatology, 33, 802, 10.1053/jhep.2001.23054

Serste, 2010, Deleterious effects of beta-blockers on survival in patients with cirrhotic and refractory ascites, Hepatology, 52, 1017, 10.1002/hep.23775